62 related articles for article (PubMed ID: 31014057)
21. CALLA trial: immunotherapy in locally advanced cervical cancer.
Kouhen F; Sqali Houssaini M
Lancet Oncol; 2024 Mar; 25(3):e94. PubMed ID: 38423062
[No Abstract] [Full Text] [Related]
22. Effects of neoadjuvant chemotherapy combined with radical laparoscopic surgery with quality nursing care on clinical efficacy and sex hormones in patients with cervical cancer.
Hu H; Wang Z; Xue L; Zhang T; Jing Y; Li Y
Am J Transl Res; 2024; 16(2):477-486. PubMed ID: 38463583
[TBL] [Abstract][Full Text] [Related]
23. The challenge of improving outcomes in locally advanced cervical cancer.
Mileshkin LR
Lancet Oncol; 2023 Dec; 24(12):1289-1291. PubMed ID: 38039987
[No Abstract] [Full Text] [Related]
24. Promising new treatment approaches for locally advanced cervical cancer.
Nierengarten MB
Cancer; 2024 Apr; 130(8):1192. PubMed ID: 38498289
[No Abstract] [Full Text] [Related]
25. Manifestation of Urinary Tract Injury during Cervical Cancer Surgery Based on CT Urography Secretion Phase Images.
Lin S; Li X; Zhang Y; Mao X; Liang X; Cheng S; Zhang L
Contrast Media Mol Imaging; 2022; 2022():2572681. PubMed ID: 35821887
[TBL] [Abstract][Full Text] [Related]
26. CALLA trial: immunotherapy in locally advanced cervical cancer.
Yang X; Zhang Y; Jia S; An J; Huang M
Lancet Oncol; 2024 Mar; 25(3):e95. PubMed ID: 38423063
[No Abstract] [Full Text] [Related]
27. Laparoscopic transperitoneal para-aortic debulking surgery in locally advanced cervical carcinoma.
Veiga N; Narváez M; Aguirre S; Lapeña S; Tarrio O; Muruzábal Torquemada JC
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35790238
[No Abstract] [Full Text] [Related]
28. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
Thelissen AAB; Jürgenliemk-Schulz IM; van der Leij F; Peters M; Gerestein CG; Zweemer RP; van Rossum PSN
Gynecol Oncol; 2022 Mar; 164(3):667-674. PubMed ID: 34969533
[TBL] [Abstract][Full Text] [Related]
29. Upper margin of para-aortic lymphadenectomy in cervical cancer.
Ouldamer L; Fichet-Djavadian S; Marret H; Barillot I; Body G
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):893-900. PubMed ID: 22553934
[TBL] [Abstract][Full Text] [Related]
30. Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
Li W; Xiong L; Zhu Q; Lu H; Zhong M; Liang M; Jiang W; Wang Y; Cheng W
BMC Cancer; 2021 May; 21(1):484. PubMed ID: 33933005
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
32. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
[TBL] [Abstract][Full Text] [Related]
33. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
[TBL] [Abstract][Full Text] [Related]
35. [The indication and surgery scope for laparoscopic extraperitoneal lymphadenectomy in locally advanced cervical cancer].
Zhong ML; Liang MR; Jiang W; Wang YN; Zeng Y; Zeng SY
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):303-308. PubMed ID: 31014057
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
